A5032708452- Dementia and Cognitive Impairment Research
- Alzheimer's disease research and treatments
- Parkinson's Disease Mechanisms and Treatments
- Schizophrenia research and treatment
- Cholinesterase and Neurodegenerative Diseases
- Geriatric Care and Nursing Homes
- Neurological Disease Mechanisms and Treatments
- Health Systems, Economic Evaluations, Quality of Life
- Neurological Disorders and Treatments
- Psychiatric care and mental health services
- Mental Health and Psychiatry
- Intensive Care Unit Cognitive Disorders
- Health disparities and outcomes
- Neurological disorders and treatments
- Ginkgo biloba and Cashew Applications
- Aging and Gerontology Research
- Pharmaceutical Practices and Patient Outcomes
- Functional Brain Connectivity Studies
- Computational Drug Discovery Methods
- Intergenerational Family Dynamics and Caregiving
- Neuroinflammation and Neurodegeneration Mechanisms
- Frailty in Older Adults
- Psychological Well-being and Life Satisfaction
- Genetic Associations and Epidemiology
- Neuroscience and Neuropharmacology Research
University of Exeter
2016-2025
Phillips Exeter Academy
2019-2025
Primary Children's Hospital
2025
Intermountain Healthcare
2025
Health & Life (Taiwan)
2022-2025
King's College London
2015-2024
Stavanger University Hospital
2006-2024
University of North Carolina at Chapel Hill
2024
University of London
2024
London School of Hygiene & Tropical Medicine
2024
Restricted accessAbstractFirst published online December 1, 2014Vascular Cognitive ImpairmentVolume 9, Issue 4_supplhttps://doi.org/10.1111/ijs.12374_18
Clinical trials have shown the benefits of cholinesterase inhibitors for treatment mild-to-moderate Alzheimer's disease. It is not known whether continue after progression to moderate-to-severe
The impact of COVID-19 on physical and mental health employment after hospitalisation with acute disease is not well understood. aim this study was to determine the effects COVID-19-related employment, identify factors associated recovery, describe recovery phenotypes. Post-hospitalisation (PHOSP-COVID) a multicentre, long-term follow-up adults (aged ≥18 years) discharged from hospital in UK clinical diagnosis COVID-19, involving an assessment between 2 7 months discharge, including detailed...
<b>Objective</b> To determine whether a systematic approach to the treatment of pain can reduce agitation in people with moderate severe dementia living nursing homes. <b>Design</b> Cluster randomised controlled trial. <b>Setting</b> 60 clusters (single independent home units) 18 homes within five municipalities western Norway. <b>Participants</b> 352 residents and clinically significant behavioural disturbances stepwise protocol for eight weeks additional follow-up four after end (33...
<h3>Abstract</h3> <b>Objective</b> To evaluate the effectiveness of a training and support intervention for nursing home staff in reducing proportion residents with dementia who are prescribed neuroleptics. <b>Design</b> Cluster randomised controlled trial blinded assessment outcome. <b>Setting</b> 12 specialist homes people London, Newcastle, Oxford. <b>Participants</b> Residents homes; numbers varied during study period. <b>Intervention</b> Training delivered to over 10 months, focusing on...
Background Falls are a major cause of morbidity and mortality in dementia, but there have been no prospective studies risk factors for falling specific to this patient population, successful falls intervention/prevention trials. This study aimed identify modifiable older people with mild moderate dementia. Methods Findings 179 participants aged over 65 years were recruited from outpatient clinics the UK (38 Alzheimer's disease (AD), 32 Vascular dementia (VAD), 30 Dementia Lewy bodies (DLB),...